OrthoPediatrics Corp. Achieves Record Growth in 2024
OrthoPediatrics Corp's Financial Performance Overview
OrthoPediatrics Corp. achieved remarkable success in 2024, reporting a full-year revenue of $204.7 million—an impressive increase of 38% compared to the previous year. The company also saw its adjusted EBITDA more than double in the fourth quarter, reaching a notable $3.0 million, up from $1.3 million in the fourth quarter of 2023. Such strong performance demonstrates OrthoPediatrics' commitment to enhancing pediatric orthopedic care.
Fourth Quarter Highlights
Revenue Growth
During the fourth quarter, the company generated total revenue of $52.7 million, representing a robust 40% increase from the same period in 2023, where revenue was $37.6 million. This growth was driven by a 52% rise in domestic revenue and a 5% increase in international revenue. U.S. sales reached $42.9 million, constituting 81% of the total revenue for the quarter.
Pediatric Impact
The fourth quarter marked a significant milestone, as OrthoPediatrics helped over 34,000 children, bringing the total to approximately 138,000 for the year. This effort has resulted in over 1.14 million children receiving care since the company’s inception, underscoring its mission to improve children’s orthopedic conditions through innovative products.
Full Year Financial Achievements
For the complete fiscal year 2024, OrthoPediatrics recorded total revenue of $204.7 million, up 38% from $148.7 million in 2023. U.S. revenue reached $161.2 million, representing a 45% increase from $111.0 million in the prior year. International markets also contributed positively, with earnings of $43.6 million, reflecting a 15% growth.
Operational Insights
Cost Management and Profitability
Despite a 33% rise in operating expenses, totaling $183.6 million for the year, OrthoPediatrics managed to improve its adjusted EBITDA by 70%, indicating effective cost management strategies. Gross profit for the fourth quarter was reported at $35.6 million with a gross profit margin of 67.5%, a testament to the efficiency of its operational model.
Investment in Technology
The company is heavily invested in R&D to enhance its offerings, particularly focusing on trauma and deformity, scoliosis, and sports medicine procedures. With more than 75 surgical systems available, OrthoPediatrics is uniquely positioned to capture a significant market share in pediatric orthopedics, further advancing its impact on children’s health.
Future Outlook
Revenue Guidance for 2025
OrthoPediatrics has reiterated its revenue guidance for 2025, forecasting earnings between $235 million and $242 million, representing a growth rate of 15% to 18% compared to 2024’s figures. This forward-looking approach aligns with its long-term goal of assisting one million children annually.
Investor Communication
The company is set to host a conference call to discuss these results, encouraging shareholders and stakeholders to engage directly with OrthoPediatrics' leadership. This transparency is vital for maintaining investor confidence and community involvement.
Conclusion
In summary, OrthoPediatrics Corp. has successfully navigated 2024 with significant growth in revenue and expanded its operational capabilities to help more children worldwide. The focus on innovation, coupled with strategic planning and execution, positions the company for continued success in the future.
Frequently Asked Questions
What were OrthoPediatrics Corp's key revenue figures for 2024?
The company reported a total revenue of $204.7 million for the year, a 38% increase over the previous year.
How much did adjusted EBITDA grow in the fourth quarter of 2024?
Adjusted EBITDA more than doubled to $3.0 million compared to $1.3 million in Q4 2023.
What is the revenue guidance for OrthoPediatrics in 2025?
OrthoPediatrics expects revenue to be between $235 million and $242 million, indicating a growth of 15% to 18% from 2024.
How many children has OrthoPediatrics helped since its inception?
Since its inception, OrthoPediatrics has helped over 1.14 million children with orthopedic conditions.
What is the primary focus of OrthoPediatrics?
OrthoPediatrics is focused on advancing pediatric orthopedics, offering a comprehensive range of surgical systems and solutions to improve children's lives.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.